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Introduction
Normal human cells gradually lose replicative capacity after a 
fi  nite number of cell divisions as a result of telomere shortening 
and irreversibly enter the growth-arrested state called replicative 
senescence (Hayfl  ick and Moorhead, 1961). This process is 
 accompanied by a series of changes, including cell enlargement, 
increased acidic β-galactosida se activity (senescence-associated 
β-galactosidase [SA–β-gal]), and alterations of chromatin 
structures. Replicative senescence has been suggested to re-
present certain aspects of organismal aging (Campisi, 2005).
It is known that cells also enter a state that is indistin-
guishable from replicative senescence after exposure to sub-
lethal doses of various types of stress, including reactive oxygen 
species, oncogenic activation, and inappropriate culture conditions. 
Such a stress-induced state is called premature senescence or 
stress-induced senescence (Serrano et al., 1997; Ramirez et al., 
2001). Accordingly, cellular senescence refers to both repli-
cative and premature senescence. Although the stimuli   inducing 
the two types of senescence appear to be considerably diverse 
(telomere dependent and independent), the stress-  induced MAPK 
p38 plays a key role in signaling such diverse stimuli to induce 
both types of senescence (Ishikawa, 2003).
Cellular senescence is not a condition that simply causes 
organismal aging to endanger the survival of individuals. Instead, 
it has been hypothesized that cellular senescence plays an adap-
tive role in preventing cells from immortalization and neoplastic 
transformation in vitro and plays a role in tumor suppression 
in vivo (Lowe et al., 2004; Campisi, 2005). Indeed, it was recently 
reported that senescent cells exist in several types of premalignant 
tumors in vivo and that cellular senescence is required to prevent 
tumorigenesis in vivo (Braig and Schmitt, 2006). Therefore, 
  cellular senescence acts as a barrier to tumorigenesis as apoptosis 
does by stably suppressing the growth of stressed cells.
The contribution of cellular senescence to tumor suppres-
sion depends on the stable maintenance of growth arrest. Altera-
tions of chromatin structure are believed to account for the 
irreversible nature of the senescent state (Narita et al., 2003). In 
the nucleus, DNA is wrapped around histone octamers to form 
nucleosomes, an array of which, in turn, is packed into higher 
ordered chromatin structures by the association of linker histone 
H1 and other chromatin proteins (Thoma et al., 1979). Senescent 
cells form characteristic heterochromatin structures called 
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C
ellular senescence is a tumor-suppressing mech-
anism that is accompanied by characteristic 
chromatin condensation called senescence-
  associated heterochromatic foci (SAHFs). We found that 
individual SAHFs originate from individual chromo-
somes. SAHFs do not show alterations of posttransla-
tional modiﬁ  cations of core histones that mark condensed 
chromatin in mitotic chromosomes, apoptotic chromatin, 
or transcriptionally inactive heterochromatin. Remarkably, 
SAHF-positive senescent cells lose linker histone H1 and 
exhibit increased levels of chromatin-bound high mobil-
ity group A2 (HMGA2). The expression of N-terminally 
enhanced green ﬂ   uorescent protein (EGFP)–tagged 
histone H1 induces premature senescence phenotypes, 
including increased levels of phosphorylated p53, 
p21, and hypophosphorylated Rb, and a decrease in 
the chromatin-bound endogenous histone H1 level but 
not in p16 level accumulation or SAHF formation. However, 
the simultaneous ectopic expression of hemagglutinin-
tagged HMGA2 and N-terminally EGFP-tagged his-
tone H1 leads to signiﬁ  cant SAHF formation (P < 0.001). 
It is known that histone H1 and HMG proteins compete 
for a common binding site, the linker DNA. These re-
sults suggest that SAHFs are a novel type of chromatin 
condensation involving alterations in linker DNA–
  binding proteins.
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senescence-associated heterochromatic foci (SAHFs; Narita 
et al., 2003; Zhang et al., 2005). SAHFs contain methylated 
histone H3 at Lys9 (H3(K9)me) and heterochromatin protein 1, 
which are typically detected in heterochromatin. It was also 
  reported that H3(K9)me is enriched at proliferation-promoting 
gene promoters specifi  cally in senescent cells that are concomi-
tant with the appearance of SAHFs but not in quiescent cells 
(Narita et al., 2003). Furthermore, Suv39h1, a histone methyl-
transferase for H3K9, is required for oncogene-induced senescence 
in mouse lymphocytes and for the suppression of lymphoma 
(Braig and Schmitt, 2006). Therefore, it is suggested that senes-
cent cells maintain the growth-arrested state, at least in part, 
by stably forming heterochromatin at proliferation-
 promoting 
gene loci.
The molecular mechanism of SAHF formation remains 
poorly understood. Although histone chaperones Asf1a and 
  histone regulation A have been reported to play a role in SAHF 
formation (Zhang et al., 2005), it is not known how these 
chaperones induce SAHFs. In this study, we have found an 
unexpected role of histone H1 in cellular senescence.
Results
Individual SAHFs originate 
from individual chromosomes
SAHFs are characterized by numerous, highly condensed 
granular DNAs spreading throughout the nucleus, as shown in 
WI-38 cells that were induced to senesce by the retroviral 
expression of oncogenic Ras (RasG12V; Fig. 1 A, bottom). 
SAHFs were observed in >80% of RasG12V-transfected cells as 
early as day 1 after drug selection. However, the degree of chro-
matin condensation appeared to increase during the following 7 d, 
during which the senescent state was stably maintained.
Because SAHFs are similar in size to inactive X chromo-
somes in WI-38 female normal fi  broblasts (Fig. 1 A, top), we 
hypothesized that each granular structure originates from indi-
vidual chromosomes. It is known that individual chromosomes 
occupy nonoverlapping and discrete spaces called chromosome 
territories (Cremer and Cremer, 2001). Previously, it was re-
ported that centromeres are localized at the periphery of chro-
mosome territories in quiescent human lymphocytes and human 
fi  broblasts (Weierich et al., 2003). We examined the number 
and position of centromeres in RasG12V-transfected senescent 
WI-38 cells using antibodies recognizing centromere protein B 
(CENP-B). Approximately 85% of CENP-B foci were colocal-
ized with SAHF signals (Fig. 1, B and C). Conversely,  70% of 
SAHFs contained one CENP-B focus at their periphery (Fig. 1, 
B and D). These results suggest that individual SAHFs originate 
from individual chromosomes.
We also performed FISH analysis using a probe specifi  c 
for chromosome 12. Optical sections of the nucleus of RasG12V-
transfected senescent WI-38 cells at 0.4-μm intervals showed 
that two chromosome 12 signals completely overlapped with 
two SAHFs in all of the fi  ve senescent cells exained (Fig. 1 E). 
Together, we conclude that each SAHF represents a heterochro-
matinized portion of an individual chromosome.
Figure 1.  A single SAHF originates from a 
single chromosome. (A) Similar sizes of SAHFs 
and inactive X chromosomes. The top two ﬁ  gures 
show a single mock-transfected WI-38 nucleus 
stained with DAPI (left) or anti-macroH2A 
  antibody (right). The inactive X chromosomes 
are indicated by arrowheads. Two separate 
RasG12V-transfected WI-38 SAHF nuclei 
stained with DAPI are shown at the bottom. 
(B) Mock- or RasG12V-transfected WI-38 cells 
were stained with anti–CENP-B antibody and 
DAPI. Schematic drawings illustrating the lo-
calization of SAHFs and CENP-B foci are 
shown (right). (C) Percentages of CENP-B foci 
that colocalized with (+) or excluded (−) 
SAHF signals (n = 418 derived from 16 senes-
cent cells). Error bars show the SD from the 
mean of three independent experiments. 
(D) Percentages of SAHFs that contained zero, 
one, or more than one CENP-B foci (n = 665 
derived from 24 senescent cells). The mean 
number of SAHFs per optical section was 27.7 ± 
5.8 (mean ± SD). (E) RasG12V-transfected 
  senescent WI-38 cells were hybridized with a 
probe speciﬁ   c for chromosome 12 (Chr12) 
and stained with DAPI. The probe stained two 
equal-sized metaphase chromosomes in WI-38 
cell metaphase spreads, showing its speci-
ﬁ  city (Fig. S1 A, available at http://www.jcb.
org/cgi/content/full/jcb.200604005/DC1). 
Enlarged images of regions A and B are opti-
cal sections at 0.4-μm intervals (right). Arrow-
heads indicate the overlapping of a single 
SAHF and chromosome 12. The results are 
representative of observations of ﬁ  ve indepen-
dent cells. Bars, 10 μm.HISTONE H1 LOSS IN CELLULAR • FUNAYAMA ET AL. 871
SAHFs are surrounded by the ICD
It has been proposed that in interphase nuclei, individual chro-
mosomes are surrounded by the interchromosome domain 
(ICD), where transcription and RNA splicing take place  (Cremer 
and Cremer, 2001). To investigate which regions in the nucleus 
are responsible for transcription in SAHF-positive senescent 
cells, RNA polymerase II was subjected to immunofl  uorescence 
(IF) analysis using specifi  c antibodies (Fig. 2 A). In mock-
  transfected WI-38 cells, anti-RNA polymerase II signals were 
diffusely distributed throughout the nucleus. In RasG12V-
  transfected senescent WI-38 cells, RNA polymerase II was spe-
cifi  cally localized in the DAPI-negative regions in a mutually 
exclusive manner with SAHFs (Fig. 2 A, bottom). Quantitative 
analyses revealed that  90% of SAHFs excluded anti-RNA 
polymerase II signals (Fig. 2 B). This result is not caused by the 
inability of the antibody to penetrate SAHFs because anti-
H3(K9)me antibody reacted with SAHFs in IF   experiments 
(see Fig. 3 A).
Next, we performed in situ labeling of nascent RNAs to 
  visualize the transcription sites (Fig. 2 C). RasG12V-transfected 
senescent WI-38 cells were permeabilized with 0.05% Triton 
X-100 and incubated with transcription buffer containing 
bromo-labeled UTP (BrU). The incorporation of BrU into na-
scent RNAs was visualized by IF analysis using anti-BrdU 
antibody. Although the shape of SAHFs was not well preserved 
after the transcription reaction, small dots of anti-BrU signals 
were exclusively localized in the DAPI-negative regions (Fig. 2 C). 
Interestingly, relatively large dots of anti-BrU signals were local-
ized at the surface of SAHFs (Fig. 2 C, bottom enlarged images). 
  Together, we conclude that in SAHF-positive senescent cells, 
  active transcription occurs at the DAPI-negative inter-SAHF 
  regions, particularly at the surface of SAHFs. This result is con-
sistent with a previous report that SAHFs do not contain active 
sites for transcription (Narita et al., 2003) and with our hy-
pothesis that the DAPI-negative regions correspond to ICDs 
(see Discussion).
SAHFs do not show histone modiﬁ  cations 
that characterize other types 
of chromatin condensation
Three types of condensed chromatin are characterized by specifi  c 
posttranslational modifi  cations of core histones: phosphorylations 
of histone H3 at Ser10 and Ser28 (H3(S10)ph and H3(S28)ph) in 
mitotic chromosomes, phosphorylation of histone H2B at Ser14 
(H2B(S14)ph) in apoptotic chromatin, and methylation of histone 
H3 at Lys9 (H3(K9)me) in transcriptionally inactive hetero-
chromatin (Peterson and Laniel, 2004). It has been argued that 
SAHFs represent transcriptionally inactive heterochromatin be-
cause SAHFs are colocalized with H3(K9)me and heterochromatin 
  protein 1 (Narita et al., 2003; Zhang et al., 2005).
To investigate to which of these distinct chromatin con-
densations SAHFs are related, we examined the posttrans-
lational modifi   cations of histone H2B and histone H3 in 
RasG12V-transfected senescent WI-38 cells (Fig. 3). In IF 
  experiments, neither anti-H3(S10)ph, anti-H3(S28)ph, nor anti-
H2B(S14)ph antibodies stained SAHFs in senescent WI-38 
cells, whereas they stained mitotic WI-38 chromosomes and 
apoptotic HeLa nuclei (Fig. 3 A). Similarly, in immunoblotting 
experiments, neither anti-H3(S10)ph nor anti-H3(S28)ph anti-
bodies detected substantial protein bands in acid-extracted (AE) 
histone fractions derived from mock- or RasG12V-transfected 
WI-38 cells, whereas strong signals were observed in histone 
fractions from colcemid-treated HeLa cells (Fig. 3 B). Although 
anti-H2B(S14)ph signals were observed in histone fractions de-
rived from mock- and RasG12V-transfected WI-38 cells, they 
were much weaker than those observed in colcemid- or UV-
treated HeLa-derived histone fractions (Fig. 3 B). These results 
indicate that SAHFs are a type of chromatin condensation that 
is distinct from those found in mitotic chromosomes or apop-
totic cells. Anti-H3(K9)me antibody reacted with SAHFs 
in senescent cells as well as the whole nuclear regions in 
 mock-transfected cells (Fig. 3 A), as previously reported (Narita 
et al., 2003). Importantly, however, immunoblotting analysis of 
AE fractions using anti-H3(K9)me antibody revealed that the 
total amount of H3(K9)me per unit cell (calibrated by anti-H2B 
signals) was not substantially different between mock- and 
RasG12V-transfected WI-38 cells (Fig. 3 B), suggesting that 
Figure 2.  SAHFs are surrounded by the ICD. (A) Mock- or RasG12V-
  transfected WI-38 cells were stained with anti-RNA polymerase II antibody 
and DAPI. (B) Percentages of SAHFs that overlapped with (+) or excluded 
(−) anti-RNA polymerase II signals (n = 341 derived from 13 senescent cells). 
Error bars represent SD. (C) Senescent cells were incubated with bromo-
  labeled UTP (BrU) and stained with anti-BrdU antibody. Enlarged   images of 
the boxed areas are shown in bottom panels. No signals were   observed 
when unlabeled UTP was used instead of BrU, when cells were treated with 
1 μg/ml α-amanitin (the concentration that inhibits RNA   polymerase II), or 
when they were treated with RNase A (Fig. S1 B, available at http://www.
jcb.org/cgi/content/full/jcb.200604005/DC1). Bars, 10 μm.JCB • VOLUME 175 • NUMBER 6 • 2006  872
the apparently strong anti-H3(K9)me signals at SAHFs refl  ect 
the condensation of DNAs. 
Histone H1 does not exist 
in the senescent cell
To analyze the molecular mechanisms involved in SAHF 
formation, we examined chromatin proteins in mock- and 
RasG12V-transfected WI-38 cells. The fractionation scheme 
used in this study is shown in Fig. 4 A. SDS-PAGE and 
  Coomassie staining of the fractionated proteins revealed several 
protein bands showing distinct patterns in mock-transfected and 
senescent cells (Fig. 4 B). Notably, a protein band having an 
  apparent molecular mass of 37 kD (hereafter referred to as a 
37-kD protein) was found in chromatin-rich fraction N2 derived 
from mock-transfected cells but not from senescent cells (Fig. 4 B, 
arrow). Mass spectrometric analysis identifi  ed this protein as 
histone H1 (Fig. 4 B).
To confi  rm that the 37-kD protein is histone H1, we per-
formed immunoblotting analyses using two different antihistone 
H1 antibodies prepared in rabbit or sheep (Fig. 4 C). Although 
the anti-H1 rabbit antibody detected a single band, the anti-H1 
sheep antibody detected two bands showing apparent molecular 
masses of 37 kD (Fig. 4 C, lanes 4, 5, 7, and 8; arrowheads). 
This is probably the result of different specifi  cities of these 
  antibodies for histone H1 variants. In both cases, no anti-H1 
signals were detected in fraction N2 derived from RasG12V-
transfected senescent WI-38 cells (Fig. 4 C, lanes 6 and 9).
To further confi  rm that histone H1 is lost from senescent 
cell chromatin, histones were prepared from fraction N2 by acid 
extraction (Fig. 4 D). Histone H1 prepared from colcemid-treated 
HeLa cells (Fig. 4 D, lanes 2 and 6) showed lower mobility than 
that prepared from nontreated HeLa cells (Fig. 4 D, lanes 1 and 5) 
and mock-transfected WI-38 cells (Fig. 4 D, lanes 3 and 7), 
which is consistent with the hyperphosphorylation of histone H1 
at metaphase. Histone H1 was not detected by Coomassie staining 
(Fig. 4 D, lane 4) or by anti-H1 sheep antibody (Fig. 4 D, lane 8). 
Collectively, we conclude that   histone H1 is lost from the chro-
matin of RasG12V-transfected senescent WI-38 cells.
To determine whether histone H1 existed in any other 
fractions of RasG12V-transfected senescent WI-38 cells, we 
performed immunoblotting analyses of whole cell extracts 
(WCEs) using anti-H1 sheep antibody (Fig. 4 E). WCEs were 
prepared from mock-transfected, RasG12V-transfected, and 
serum-starved quiescent (0.1% FBS) WI-38 cells by directly 
suspending cell pellets in SDS sample buffer. No 37-kD histone 
H1 band was detected in the WCE from senescent cells 
(Fig. 4 E, lane 3). Time-course experiments showed that the 
  majority of histone H1 was lost between days 2 and 3 after the 
Figure 3.  SAHFs do not show histone modiﬁ  cations  that 
characterize three types of chromatin condensation. (A) Mock- 
or RasG12V-transfected WI-38 cells as well as HeLa cells irra-
diated with 100 Jm
−2 UV rays (HeLa-UV) were stained with 
antihistone antibodies and DAPI. Mitotic WI-38 nuclei and 
apoptotic HeLa nuclei are shown by arrowheads and arrows, 
respectively. (B) WI-38 cells were mock- or RasG12V-
transfected and harvested at the indicated time points after 
drug selection. HeLa cells were untreated (non-treat), treated 
with 100 ng/ml colcemid, or irradiated with 100 Jm
−2 UV 
rays (UV). Histones were prepared by acid extraction and an-
alyzed by immunoblotting. Percentages of SAHF-positive cells 
are shown (bottom; n = 300). Bars, 10 μm.HISTONE H1 LOSS IN CELLULAR • FUNAYAMA ET AL. 873
completion of drug selection in the RasG12V-transfected cells 
(Fig. 4 F). These results indicate that histone H1 is lost from the 
entire cell in the Ras-induced senescence.
Histone H1 is lost from various types 
of senescent cells
We extended the experiments to include other types of normal 
human fi  broblasts (MRC-5, IMR-90, and BJ; Fig. 5 A). The 
amount of histone H1 was moderately decreased in RasG12V-
transfected MRC-5 and IMR-90 cells (Fig. 5 A, lanes 4 and 6) 
but not in BJ cells (Fig. 5 A, lane 8). Importantly, as shown in Fig. 
5 A, the extent of histone H1 reduction is well correlated with the 
frequency of SAHF-positive cells after RasG12V expression. We 
also examined histone H1 in cellular senescence induced by 
other types of stimuli. Histone H1 was lost from or considerably 
decreased in senescent cells induced by extensive culturing 
  (replicative senescence) or by the ectopic expression of a consti-
tutive active form of MKK6 (MKK6EE) that activates the stress-
induced MAPK p38 (Fig. 5 B; Wang et al., 2002; Iwasa et al., 
2003). Moreover, the extent of histone H1 reduction was corre-
lated with the frequency of SAHF-positive cells. Together, the 
loss of histone H1 is observed not only in RasG12V-transfected 
WI-38 cells but also in other types of RasG12V-transfected 
  normal human fi  broblasts and in senescent cells induced by other 
stimuli, extending its correlation with SAHF formation.
Loss of histone H1 from senescent cell 
chromatin is posttranslationally regulated
The expressions of most histone genes are coupled with DNA 
replication (Gunjan et al., 2005). As senescent cells do not 
  undergo DNA replication (Serrano et al., 1997; Narita et al., 2003), 
it is expected that histone H1 is transcriptionally repressed. 
Indeed, RT-PCR analysis showed that the mRNA expression of 
HIST1H1D, one of the major histone H1 genes encoding histone 
H1.3, was repressed in RasG12V-transfected senescent WI-38 
cells compared with young proliferating cells (10% FBS; Fig. 6 A, 
lanes 1 and 3). This raised the possibility that the loss of histone 
H1 from senescent cell chromatin is simply caused by the 
repression of de novo histone H1 synthesis. We found that the 
mRNA expression of HIST1H1D was not detected in quiescent 
WI-38 cells that had been serum starved for 1 wk (note that 1 wk 
is long enough for RasG12V   expression to cause histone H1 
loss; Figs. 4 F and 6 A, lane 2), as expected from the observation 
that the fraction of quiescent cells in S phase was very small 
Figure 4.  Histone H1 is lost from the senescent cell. 
(A) Scheme showing the fractionation of WI-38 cells to 
isolate chromatin fractions. Hoechst 33342 staining 
of the chromatin-rich fraction (fraction N2) showed 
that SAHFs are retained in the nuclei present in this 
fraction (not depicted). (B) Coomassie staining of frac-
tions C, N1, and N2 derived from mock- and 
RasG12V-transfected WI-38 cells. The 37-kD protein 
band from which peptide sequences of human histone 
H1 were obtained (right) is indicated with an arrow. 
(C) Chromatin-rich fractions (N2) were prepared as 
shown in A and analyzed by Coomassie staining and 
immunoblotting. AE fractions prepared from mock-
transfected cells were used for comparison. The 
amount of loaded proteins was standardized with 
core histones (vertical bold line). Arrowheads indicate 
the positions of histone H1. The band of which signal 
intensity appeared to increase in RasG12V-transfected 
cells (lane 9, open circle) was detected in the absence 
of the ﬁ  rst antibody, indicating that it is unrelated to 
histone H1 (Fig. S2 A, available at http://www.jcb.
org/cgi/content/full/jcb.200604005/DC1). (D) His-
tones were prepared from mock- or RasG12V-trans-
fected WI-38 cells by acid extraction and analyzed by 
Coomassie staining and immunoblotting. HeLa cells 
with or without colcemid treatment were used for 
  comparison. (E) Quiescent cells were prepared by 
  culturing mock-transfected cells in 0.1% FBS for 
1 wk. WCEs were prepared from mock-transfected, 
RasG12V-transfected, or serum-starved quiescent 
cells and analyzed by immunoblotting. AE fractions 
obtained from mock-transfected cells were also 
  examined. Two bands that showed slightly slower and 
faster migration than the 37-kD band were detected in 
RasG12V-transfected cells (lane 3; open and ﬁ  lled cir-
cles, respectively). However, these bands were also 
detected in the absence of the ﬁ  rst antibody, indicat-
ing that they are unrelated to histone H1 (Fig. S2 B). 
(F) WCEs were prepared from mock- or RasG12V-
transfected cells at the indicated time points after drug 
selection. Samples were analyzed by immunoblotting.JCB • VOLUME 175 • NUMBER 6 • 2006  874
(Fig. 6 B, right). Nevertheless, the serum-starved quiescent WI-38 
cells contained the same amount of chromatin-bound histone 
H1 protein as proliferating WI-38 cells cultured with 10% FBS 
(Fig. 6 C), arguing that repression of the de novo histone H1 
synthesis itself is not suffi  cient for the loss of histone H1 protein 
from chromatin. Therefore, the loss of histone H1 from senes-
cent cells is most likely posttranslationally regulated.
Ectopic expression of histone H1 does not 
prevent RasG12V-induced senescence
To examine whether the loss of histone H1 has a causative role in 
senescence phenotype induction and SAHF formation, we pre-
pared WI-38 cells that express short hairpin RNA to knock down 
the expression of histone H1. However, despite repeated trials, 
we did not succeed in knocking down the genes (unpublished 
data), probably as a result of the presence of multiple histone H1 
variant genes.
We next examined whether or not the ectopic expres-
sion of histone H1 prevented RasG12V-induced senescence. 
Young proliferating WI-38 cells were fi  rst infected with retrovirus 
(driven by the weak long terminal repeat promoter or the strong 
cytomegalovirus promoter) or lentivirus (driven by the strong 
EF1α promoter) expressing untagged histone H1 and were in-
fected with RasG12V-expressing retrovirus (Fig. 7). The ecto-
pic expression of histone H1 only slightly increased the amount 
of chromatin-bound histone H1 in RasG12V-transfected cells 
(Fig. 7, compare lane 2 with lanes 4, 6, and 8). However, it did 
not substantially prevent the RasG12V-induced loss of histone 
H1, growth arrest, or SAHF formation (Fig. 7) even when his-
tone H1 was expressed by the strong cytomegalovirus and EF1α 
promoters. Together, these experiments do not conclude whether 
or not histone H1 loss has any causative role in cellular senes-
cence because we could not manipulate the histone H1 level 
suffi  ciently to induce phenotypic changes.
Ectopic expression of N-terminally 
EGFP-tagged histone H1 induces 
senescence phenotypes
We next examined whether the ectopic expression of various 
types of recombinant histone H1 alone had any effects on WI-38 
cells. Young proliferating WI-38 cells were transfected with 
one of four retroviruses expressing histone H1 fused to EGFP or 
HA (Fig. 8 A, top). Fluorescence microscopy revealed that all 
histone H1 fusion proteins were localized in nuclei and colocal-
ized with mitotic chromosomes (Fig. 8 A and Fig. S3 A, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200604005/DC1), 
indicating their profi   cient chromatin binding in nuclei. 
Unexpectedly, cells expressing N-terminal EGFP-H1 fusion 
proteins (N fusions 1 and 2) showed decreased levels of 
  chromatin-bound endogenous histone H1 compared with cells 
expressing C fusion or HA-H1 (Fig. 8 B). N fusions 1 and 2 
have different linker amino acid sequences between EGFP and 
the histone H1 open reading frame (see Materials and methods) 
but showed the same phenotypes in WI-38 cells.
Interestingly, concomitant with the decreases in histone 
H1 protein levels, the expression of N fusions caused severe 
growth defects in young WI-38 cells as revealed by the growth 
curves (Fig. 8 C) and the BrdU incorporation assay (Fig. 8 D, 
top). N fusions also induced a large, fl  at morphology and in-
creased the percentage of SA–β-gal–positive cells (Fig. S3 B 
and Fig. 8 D, bottom), suggesting that the ectopic expression 
of N fusions induced premature senescence in WI-38 cells. 
Consistent with this idea, cells expressing N fusions showed 
decreased levels of phosphorylated Rb and cyclin A and increased 
levels of p21 and phosphorylated p53 (Fig. 8 E), which are typ-
ical molecular markers for senescent cells. In contrast, the 
ectopic expression of C fusion or HA-H1 did not induce senes-
cence markers or decrease the levels of endogenous histone H1. 
The ectopic expression of untagged histone H1 slightly in-
creased the levels of histone H1 protein but did not induce se-
nescence phenotypes in WI-38 cells either (Fig. 8 F, lane 3). 
Collectively, these results suggest that the induction of senes-
cence phenotypes is correlated with the decreased levels of 
chromatin-bound endogenous histone H1. Notably, N fusions 
did not induce the accumulation of p16 or SAHF formation 
(Fig. 8, E and A, DNA).    
Figure 5.  Histone H1 is lost from various types of senescent cells. 
(A) Mock- or RasG12V-transfected cells (WI-38, MRC-5, IMR-90, and BJ) 
were fractionated as shown in Fig. 4 A at day 5 after drug selection. AE 
and cytoplasmic fractions (C) were analyzed by immunoblotting. The 
amounts of loaded proteins were calibrated by anti-H2B or antiactin 
signals, respectively. Transfected cells were scored for the percentages of 
BrdU- and SAHF-positive cells at harvest time (bottom; n = 200). (B) WI-38 
cells were induced to senesce by the retroviral expression of RasG12V or 
a constitutive active form of MKK6 (MKK6EE). Replicative senescent cells 
were analyzed at 57 population doubling levels, at which cells could not 
reach conﬂ  uence for 3 wk. Quiescent cells were prepared by culturing the 
mock-transfected cells in 0.1% FBS for 1 wk. WCEs were analyzed by 
immunoblotting. The percentages of BrdU- and SAHF-positive cells are 
indicated (bottom; n = 200).HISTONE H1 LOSS IN CELLULAR • FUNAYAMA ET AL. 875
Coexpression of N-fusion histone H1 
and HA-tagged HMGA2 induces 
SAHF formation
We found that a protein band showing an apparent molecular 
mass of 22 kD was accumulated in the AE fraction prepared from 
RasG12V-transfected senescent WI-38 cells (Fig. 9 A, arrowhead). 
Mass spectrometric analysis and immunoblotting analysis identi-
fi  ed this protein as high mobility group A2 (HMGA2; Fig. 9 A). 
Similar observations have been reported recently (Narita et al., 
2006). Time-course experiments indicated that the accumula-
tion of chromatin-bound HMGA2 was inversely correlated with 
the loss of histone H1 from chromatin (Fig. 9 B, lanes 5–8). 
Interestingly, the amount of chromatin-bound HMGA2 was also 
increased in senescent WI-38 cells expressing both histone H1 
and RasG12V (Fig. 9 C). We also showed that macroH2A was 
incorporated into chromatin in RasG12V-transfected cells as pre-
viously reported (Fig. 9 B, lanes 5–8; Zhang et al., 2005).
To investigate the role of macroH2A and HMGA2 in se-
nescence phenotype induction and SAHF formation, young pro-
liferating WI-38 cells were transfected with HA-tagged HMGA2 
(HA-HMGA2) or FLAG-tagged macroH2A (macroH2A–FLAG; 
Fig. 9 D). The amounts of chromatin-bound HA-HMGA2 and 
macroH2A–FLAG were comparable with those of endogenous 
proteins observed in RasG12V-transfected cells (Fig. 9 D, lanes 
2–4; and Fig. S4 A, available at http://www.jcb.org/cgi/content/
full/jcb.200604005/DC1). Furthermore, IF analysis revealed that 
both HA-HMGA2 and macroH2A–FLAG were localized in 
 nuclei (Fig. S4 B and not depicted). The expression of HA-HMGA2 
or macroH2A–FLAG did not induce senescence phenotypes, in-
cluding growth defects, a large, fl  at morphology, or SAHF forma-
tion (Fig. 9 D, bottom; Fig. S4, C and D; and not depicted). 
To investigate whether the overexpression of HMGA2 or 
macroH2A collaborates with the reduced endogenous histone H1 
level found in N fusion–expressing cells, young WI-38 cells 
expressing HA-HMGA2 or macroH2A–FLAG were further 
transfected with the retrovirus expressing N fusion 2 and were 
scored for SAHF-positive cells (Fig. 9, E and F). The coexpres-
sion of HA-HMGA2 and N fusion 2 signifi  cantly increased the 
percentage of SAHF-positive cells (P < 0.001), whereas the 
coexpression of macroH2A–FLAG and N fusion 2 did not. The 
coexpression of HA-HMGA2 and N fusion 1 led to similar 
results, but the coexpression of HA-HMGA2 and HA-H1 did 
not (Fig. S5), suggesting that the removal of endogenous histone 
H1 from chromatin by N-fusion histone H1 rather than the pro-
duction of recombinant histone H1 itself is important for SAHF 
formation. Together, these results indicate that the simultaneous 
overexpression of HA-HMGA2 and N-fusion histone H1 leads 
to SAHF formation. However, cells coexpressing HA-HMGA2 
and N fusion 2 did not show the accumulation of p16, at least up 
to day 3 after drug selection (unpublished data).
Discussion
In this study, we found that the induction of senescence pheno-
types is accompanied by the loss of linker histone H1 from 
and the accumulation of HMGA2 to chromatin. The loss of 
  histone H1 is not simply through the repression of histone H1 
mRNA expression but is most likely through a posttranslational 
  mechanism. The ectopic expression of N-terminally EGFP-tagged 
Figure 6.  Loss of histone H1 from senescent 
cell chromatin is posttranslationally regulated. 
(A) Mock- and RasG12V-transfected WI-38 
cells in 10% FBS and quiescent cells prepared 
by culturing noninfected WI-38 cells in 0.1% 
FBS for 1 wk were analyzed for mRNA expres-
sions of HIST1H1D (encoding histone H1.3) 
and GAPDH by RT-PCR from total RNA in the 
presence (lanes 1–3) or absence (lanes 4–6) 
of reverse transcriptase (RT). (B) Cells were 
stained with DAPI (left) or propidium iodide 
and were analyzed for DNA contents with 
a laser-scanning cytometer (right). Although 
RasG12V-transfected cells completely stopped 
dividing, the laser-scanning cytometer analysis 
showed a large percentage of the cells in 
S phase. It is not clear whether this reﬂ   ects 
cell cycle arrest in S phase or whether the 
  laser-scanning cytometer did not accurately 
measure DNA contents in senescent cells, 
  presumably as a result of the highly irregular patterns of DNA staining. (C) AE fractions were prepared from cells described in A and were analyzed by 
Coomassie staining (left) and immunoblotting (right). Bars, 10 μm.
Figure 7.  Ectopic expression of histone H1 does not prevent RasG12V-
  induced senescence. WI-38 cells were ﬁ  rst infected with retrovirus (retro) or 
lentivirus (lenti) expressing histone H1 under the control of the indicated 
promoters and were infected with RasG12V-expressing retrovirus. Cell 
  lysates were prepared from transfected cells at day 7 after drug selection 
and analyzed by immunoblotting. Transfected cells were scored for the 
percentages of BrdU- and SAHF-positive cells at day 3 after drug selection 
(bottom; n = 200). CMV, cytomegalovirus; LTR, long terminal repeat.JCB • VOLUME 175 • NUMBER 6 • 2006  876
  histone H1 in   WI-38 cells acutely induces senescence pheno-
types except SAHF formation and p16 accumulation, which is 
concomitant with a decrease in the chromatin-bound endoge-
nous histone H1 protein level. This result suggests that distinct 
pathways are responsible for p53-p21-pRb–dependent growth 
arrest and SAHF formation with or without p16 accumulation 
in cellular senescence. Notably, when HMGA2 was coexpressed 
in this condition, signifi  cant amounts of SAHFs were formed 
(P  0.001), suggesting that the substitution of HMGA2 for 
histone H1 is required for SAHF formation. Previously, it was 
reported that the amount of histone H1 protein was decreased in 
replicative senescence (Mitsui et al., 1980). However, the bio-
logical signifi  cance of that observation has remained a mystery. 
We suggest that SAHFs are a novel type of chromatin conden-
sation involving alterations in linker DNA–binding proteins.
SAHFs are a novel type 
of chromatin condensation
We propose that individual SAHFs originate from individual 
chromosomes. This proposition is based on several lines of 
evidence. The majority of SAHFs contained one centromere at 
their periphery and was surrounded by DAPI-negative regions 
where RNA polymerase II exists and de novo transcription 
  occurs. Such features of the DAPI-negative regions have been 
proposed and described for ICD, a system of channels that run 
between chromosome territories and metabolize and transport 
RNA transcripts (Cremer and Cremer, 2001). Finally, the painting 
probe for chromosome 12 stained exactly one SAHF.
A recent study has demonstrated the presence of RNA 
transcripts and transcription factors inside the chromosome 
  territory, challenging the conventional ICD model (Williams, 
2003). A revised model has been developed in which a single 
chromosome territory is composed of condensed chromatin 
subdomains as well as channels canalizing the territory and ul-
timately draining into ICDs. Active genes are proposed to exist 
on the surface of the condensed chromatin subdomains inside 
the territory. We found that RNA polymerase II exists more or 
less diffusely throughout the nucleus in young WI-38 cells, 
supporting this revised model. However, we also found that 
RNA polymerase II and RNA transcripts are excluded from 
SAHFs in senescent cells. These observations suggest that 
SAHF is a heterochromatinized portion of an individual chro-
mosome whose chromatin is so tightly condensed that active 
genes are virtually excluded.
Figure 8.  Ectopic expression of N-terminally EGFP-tagged 
histone H1 induces premature senescence. (A) Nuclear local-
ization of histone H1 fusion proteins. Schematic structures of 
histone H1 (histone H1.3) fusion proteins are indicated (top). 
Transfected WI-38 cells were examined for EGFP and stained 
with anti-HA antibody (HA) and DAPI (DNA) at day 2 after 
drug selection. Images are projections of whole nuclei. 
(B) Cell lysates were prepared from transfected cells at day 3 
after drug selection and analyzed by immunoblotting. The 
amounts of loaded proteins were calibrated by anti-H2B 
  signals. Endogenous histone H1 (H1) and H1 fusion proteins 
were analyzed using anti-H1 sheep antibody. (C) The number 
of transfected cells was scored at the indicated time points 
  after drug selection. Error bars represent SD. (D) Transfected 
cells were scored for the percentages of BrdU- (top) and SA–
β-gal–positive cells (bottom) at days 3 and 5 after drug selec-
tion, respectively (n = 200). (E) Cell lysates were prepared 
from transfected cells at day 3 after drug selection and ana-
lyzed by immunoblotting. The amounts of loaded proteins 
were calibrated by antiactin signals. (F) Cell lysates were an-
alyzed as described in B and E. The percentages of BrdU- 
and SAHF-positive cells are indicated (bottom; n = 200). 
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SAHFs are a novel type of chromatin condensation not 
only from a cytological viewpoint but also from a biochemical 
viewpoint. We found that SAHFs do not show the phosphoryla-
tion of histone H3 at either Ser10 or Ser28 or the phosphoryla-
tion of histone H2B at Ser14, which are hallmarks of mitotic 
and apoptotic chromatins, respectively. It has been reported that 
SAHFs exhibit features of transcriptionally inactive heterochro-
matin (Narita et al., 2003; Zhang et al., 2005). Consistent with 
such earlier studies, we also observed that SAHFs were strongly 
stained with anti-H3(K9)me antibody. However, we found that 
the total amount of H3(K9)me remained unchanged at least for 
1 wk after the induction of senescence, during which the ma-
jority of cells became SAHF positive. These results suggest that 
although de novo histone methylation may occur locally and 
repress gene expression at some particular gene loci, a genome-
wide increase in the total amount of H3(K9)me does not occur 
in senescent cells. Although these results do not exclude the 
  involvement of transcriptionally inactive heterochromatin in 
SAHFs, they suggest that SAHFs are generated by a mechanism 
that should be distinguished from those involved in conven-
tional chromosome condensation and heterochromatinization.
Loss of histone H1 and 
senescence phenotypes
We found that linker histone H1 is lost from senescent cells. 
Because it is generally believed that histone H1 facilitates chro-
matin condensation and acts mainly as a transcriptional repressor 
(Hayes and Hansen, 2001), it was unexpected that histone H1 
was lost instead of increased in SAHFs. Although we could not 
defi  nitely conclude whether the loss of histone H1 is causally 
linked to the induction of senescence phenotypes and SAHF 
formation, the following observations suggest that the altera-
tions in histone H1 metabolism are involved in a senescence-
  inducing mechanism. First, the amount of histone H1 protein 
was lost or considerably reduced in a variety of cellular senes-
cence occurring in different cell types and through different 
stimuli. Second, the extent of histone H1 loss in such occasions 
was well correlated with the frequency of SAHF formation. 
Figure 9.  Coexpression of HA-tagged 
HMGA2 and N-fusion histone H1 induces 
SAHF formation. (A) AE fractions were pre-
pared from mock- and RasG12V-transfected 
WI-38 cells and analyzed by Coomassie stain-
ing and immunoblotting. A protein band hav-
ing an apparent molecular mass of 22 kD from 
which peptide sequences of human HMGA2 
were obtained is indicated with an arrowhead. 
(B) AE fractions were prepared from mock- 
and RasG12V-transfected WI-38 cells at the 
  indicated time points after drug selection and 
were analyzed by immunoblotting. Histone H1 
was analyzed using anti-H1 rabbit antibody. 
(C) Cell lysates were prepared from transfected 
WI-38 cells at day 7 after drug selection and 
were analyzed by immunoblotting as de-
scribed in Fig. 8 B. CMV, cytomegalovirus; 
LTR, long terminal repeat. (D) Transfected 
  WI-38 cells were ana  lyzed as described in B. 
Histone H1 was analyzed using anti-H1 sheep 
antibody. The percentages of SAHF-positive 
cells are indicated (bottom; n  = 200). (E) 
Transfected WI-38 cells were scored for the 
percentage of SAHF-positive cells at day 3 af-
ter drug selection (top; n = 200). *, P < 0.001 
by t test. Error bars represent SD. Transfected 
WI-38 cells were analyzed as described in 
Fig. 8 B (bottom). (F) Representative images of 
SAHF-positive cells. Transfected WI-38 cells 
were stained with DAPI at day 3 after drug 
  selection. Arrowheads indicate SAHF-positive 
nuclei. (G) A model of the role of histone H1 
dissociation and HMGA2 accumulation in in-
ducing growth arrest and SAHF formation. 
p53-p21-pRb–dependent growth arrest is medi  -
ated by either histone H1–free chromatin itself 
or signaling elicited by unbound histone H1. 
SAHFs are formed when histone H1 is re-
placed with HMGA2, which occurs only when 
RasG12V is expressed or N-fusion H1 and 
HMGA2 are coexpressed. Bars, 10 μm.JCB • VOLUME 175 • NUMBER 6 • 2006  878
Finally, senescence phenotypes except SAHF formation and 
p16 accumulation were induced in young WI-38 cells by the ec-
topic expression of N fusion but not of C fusion, HA-H1, or un-
tagged recombinant H1 proteins. These proteins were produced 
at similar levels (Fig. 8, B and F) and were effi  ciently bound to 
chromatin (Fig. 8 A and Fig. S3 A), suggesting that senescence 
was not induced by nonspecifi  c effects caused by the over-
production of nonfunctional histone H1 proteins. 
Interestingly, the senescence induction and reduced level 
of endogenous histone H1 were well correlated: only N fusions 
showed both effects, whereas the other recombinant histone H1 
proteins showed neither. We do not know why N fusions but not 
C fusion affect the level of endogenous histone H1 and induce 
SAHF formation. It has been reported that N-terminal GFP-
tagged histone H1.1 binds to chromatin with higher affi  nity than 
C-terminal GFP-tagged histone H1.1 in SK-N-SH neuroblas-
toma cells (Hendzel et al., 2004). It is possible that such different 
affi  nities cause different stabilities of endogenous histone H1 
protein. Alternatively, N-terminal GFP may perturb the incor-
poration of endogenous histone H1 into neighboring nucleo-
somes by steric hindrance, for example.
Embryonic stem cells homozygously deleted of three out 
of six somatic histone H1 variant genes were viable and showed 
apparently normal growth. Interestingly, however, the DNA 
methylation and expression patterns of some specifi  c loci, in-
cluding imprinted genes, were deregulated (Fan et al., 2005). 
These results raise the possibility that the absence of histone H1 
in senescent cells may specifi  cally affect the expression of genes 
involved in senescence phenotypes (Fig. 9 G).
The amounts of histone proteins, especially those of 
  chromatin-unbound forms, are strictly regulated in cells. It has 
been reported that the chromatin-unbound free core histones are 
degraded in a Rad53-dependent manner in yeast. In rad53 cells, 
chromatin-unbound core histones persist at the completion of 
S phase, leading to impaired cell growth (Gunjan et al., 2005). 
Therefore, another interesting possibility is that the production 
of free histone H1, not the reduction of chromatin-bound 
 histone  H1, positively triggers a signal leading to senescence 
(Fig. 9 G). A hypothesis reminiscent of this case was reported 
previously: after exposure to x rays, histone H1.2, a histone H1 
variant, moves to the cytoplasm, where it induces cytochrome c 
release from mitochondria to activate caspase-dependent de-
struction cascades (Konishi et al., 2003).
Altered balance between histone H1 
and HMGA2 bound to chromatin 
in SAHF formation
Recent studies have emphasized the dynamic binding of histone 
H1 to chromatin. Histone H1 associates with and dissociates 
from chromatin in a rapid turnover (Lever et al., 2000; Bustin 
et al., 2005). Histone H1 dissociation from chromatin may be 
enhanced by activities that destabilize the histone H1–chromatin 
association. HMG proteins are the second most abundant chro-
matin proteins after histones and consist of three subfamilies: 
HMGA, HMGB, and HMGN. It was reported that HMG 
proteins and histone H1 compete with each other for the same 
binding site, the linker DNA. Specifi  cally, microinjected excess 
amounts of HMG proteins leads to high turnover rates and 
  reduces the residence time of endogenous chromatin-bound 
  histone H1, presumably by being excluded from chromatin by 
the excess HMG proteins (Catez et al., 2004).
On the surface, the failure of the ectopic expression of 
histone H1 to prevent RasG12V-induced senescence appears 
to refute the causative role of histone H1 loss in senescence 
  induction. However, the amounts of chromatin-bound HMGA2 
and chromatin-bound histone H1 were similarly increased and 
reduced, respectively, in RasG12V-expressing cells irrespective 
of histone H1 coexpression (Figs. 7 and 9 C), suggesting that 
RasG12V expression shifts the balance of HMGA2 and histone 
H1 association with the linker DNA in favor of HMGA2 (Fig. 9 G). 
The ectopic expression of histone H1 may fail to restore the bal-
ance in favor of histone H1 to a degree that is suffi  cient to pre-
vent senescence in the RasG12V-expressing condition. It is not 
clear why the ectopic expression of histone H1 even by the 
strong promoters failed to restore the chromatin-bound histone 
H1 protein level in RasG12V-transfected cells. It is possible that 
histone H1 is actively removed from chromatin in such cells. 
Alternatively, senescent cell chromatin may be incompetent to 
incorporate newly synthesized histone H1. It is also not clear 
how endogenous histone H1 disappears from senescent cells. 
Further studies are warranted to determine whether histone H1 
loss plays a causative role in senescence induction.
When HMGA2 was ectopically expressed in young WI-38 
cells to the level found in RasG12V-expressing cells, no se-
nescence phenotypes were induced (Fig. 9 D and Fig. S4). 
  Conversely, when the amount of chromatin-bound histone H1 
was reduced by N-fusion expression, no SAHFs were formed 
either (Fig. 8 A). SAHFs were formed only when N fusions 
  accompanying histone H1 loss and HMGA2 were coexpressed. 
We hypothesize that both the reduced association of histone H1 
and the increased association of HMGA2 with chromatin, which 
refl  ect the substitution of HMGA2 for histone H1, are required 
for SAHF formation (Fig. 9 G). Therefore, SAHFs may be 
viewed as heterochromatin in which the balance of the two 
major linker DNA–binding proteins (histone H1 and HMGA2) 
is altered.
We also found that the coexpression of N fusion 2 and 
HA-HMGA2 did not induce p16 accumulation, at least up to 
day 3 after drug selection. Additional conditions may be re-
quired to trigger the full-blown senescence program, including 
the activation of p16.
Materials and methods
Cell culture and retroviral gene transfer
Normal human ﬁ  broblasts WI-38, MRC-5, and IMR-90 were purchased 
from Coriell Cell Repositories. BJ was purchased from American Type 
  Culture Collection. The cells were cultured in DME supplemented with 10% 
FBS. Phoenix cells (provided by G. Nolan, Stanford University, Stanford, 
CA) were transfected with retroviral vectors using FuGene 6 (Roche). 
Culture supernatants were supplemented with 8 μg/ml polybrene (Sigma-
Aldrich) and incubated with target cells. Infected cells were selected by 
incubating with 2.5 μg/ml puromycin (Sigma-Aldrich) or 600 μg/ml 
G418 (Nacalai Tesque) for 3 or 5 d, respectively.
Retroviral vectors used in this study are pMX-puro and pMX-neo (gift 
from T. Kitamura, University of Tokyo, Tokyo, Japan). MKK6EE cDNA was 
provided by E. Nishida (Kyoto University, Kyoto, Japan) and Y. Goto HISTONE H1 LOSS IN CELLULAR • FUNAYAMA ET AL. 879
(University of Tokyo, Tokyo, Japan). MacroH2A cDNA was provided by 
K. Shibahara (National Institute of Genetics, Mishima, Japan). Amino acid 
sequences between EGFP and the histone H1 open reading frame in N 
and C fusions are as follows: EGFP-Leu-Glu-Ala-Ala-Ala-Ile-Gly-Ser-H1 for 
N fusion 1, EGFP-Pro-Glu-Phe-Thr-H1 for N fusion 2, and H1-Pro-Glu-Phe-
Thr-EGFP for C fusion.
Antibodies
The following primary antibodies were used: anti-RNA polymerase II 
(8WG16), anti-HA (16B12), and anti-HMGA2 (Covance); anticyclin A, 
anti-p16, anti-p21, anti-p53 (Bp53-12), anti–H-Ras, and anti-MKK6 (Santa 
Cruz Biotechnology, Inc.); antiphospho-S10 histone H3, antiphospho-S14 
histone H2B, antidimethyl-K9 histone H3, antihistone H2B, and antihis-
tone macroH2A1 (Upstate Biotechnology); anti-BrdU (BMC9318; Roche); 
antiactin (Chemicon); antihistone H1 sheep (Abcam); anti-Rb (G3-245; 
BD Biosciences); antiphospho-S15 p53 (Cell Signaling); anti–CENP-B 
(provided by H. Masumoto, Nagoya University, Nagoya, Japan); 
  antiphospho-S28 histone H3 (provided by T. Urano, Nagoya University); 
and antihistone H1 rabbit (provided by K. Ohsumi, Tokyo Institute of 
Technology, Kanagawa, Japan).
IF and DNA content analyses
Cells were ﬁ  xed with 3% formaldehyde in PBS at 4°C for 20 min and permea-
bilized with Triton buffer (TB; 0.5% Triton X-100 in PBS) for 10 min. After 
incubation in TB containing 5% skim milk for 1 h, the cells were treated with 
primary antibody and incubated with AlexaFluor488- or Cy-3–conjugated 
secondary antibody (Invitrogen and Jackson ImmunoResearch Laborato-
ries, respectively). DNA was stained with 1 μg/ml DAPI in PBS for 10 min. 
Images were acquired at room temperature with a deconvolution micro-
scope (IX70; Olympus; and DeltaVision; Applied Precision) equipped 
with a 40× NA 1.35 oil immersion objective lens (UApo/340; Olympus) 
and a charge-coupled device camera (CH350; Photometrics). The im-
ages were deconvolved and processed by SoftWoRx (Applied Precision) 
and Photoshop (Adobe). Unless otherwise mentioned, images are single 
opti  cal sections.
For DNA content analysis, cells were ﬁ  xed with 3% formaldehyde 
and permeabilized with TB. Then, the cells were incubated in PBS con-
taining 50 μg/ml propidium iodide and 200 μg/ml RNase A at 37°C for 
30 min. DNA content was analyzed with a laser-scanning cytometer 
(LSC2; Olympus).
In situ labeling of nascent RNAs and BrdU incorporation assay
In situ labeling of nascent RNAs was performed as previously described 
(Wansink et al., 1993) with slight modiﬁ  cations. In brief, cells were rinsed 
with glycerol buffer (20 mM Tris-HCl, pH 7.5, 5 mM MgCl2, 0.5 mM 
EGTA, 25% glycerol, and Complete protease inhibitors [Roche]) contain-
ing 0.05% Triton X-100 at 4°C for 1 min. Then, the cells were incubated 
in transcription buffer (50 mM Tris-HCl, pH 7.5, 10 mM MgCl2, 0.5 mM 
EGTA, 100 mM KCl, 25% glycerol, 25 μM S-adenosylmethionine 
[New England Biolabs, Inc.], 0.5 mM each of BrU [Sigma-Aldrich], ATP, 
CTP, and GTP, 8 U/ml RNase inhibitor [Takara], and Complete protease 
inhibitors) at 35°C for 10 min. Incorporated BrU was visualized by IF 
analysis  using anti-BrdU antibody. For BrdU incorporation assay, cells 
were cultured in DME supplemented with 100 μM BrdU for 5 h, ﬁ  xed 
with 2% formaldehyde at 4°C for 15 min, and permeabilized with TB at 
room temperature for 5 min. After treatment with 1.5 N HCl at room tem-
perature for 10 min, incorporated BrdU was visualized by IF analysis using 
anti-BrdU antibody.
FISH
FISH was performed using a chromosome 12–speciﬁ  c probe conjugated 
with Cy-3 (StarFISH; Cambio). FISH on metaphase spreads was performed 
according to the manufacturer’s protocol. FISH on senescent cells was per-
formed as described previously (Croft et al., 1999).
Subcellular fractionation, mass spectrometry, and immunoblotting
Cells were harvested and incubated in buffer A (40 mM Tris-HCl, pH 7.4, 
1 mM EDTA, 0.5 mM DTT, 1 mM sodium orthovanadate, 1 mM sodium ﬂ  u-
oride, 100 nM okadaic acid, and Complete protease inhibitors) contain-
ing 10 mM NaCl at 4°C for 10 min. Then, the cells were passed through 
a 26- (mock-transfected cells) or 23-gauge (RasG12V-transfected cells) 
needle  20 times to disrupt the cell membrane and were centrifuged at 
1,000 g for 10 min at 4°C. Supernatants were removed (fraction C), and 
pellets were incubated in buffer A containing 150 mM NaCl and 0.2% 
  Triton X-100 at 4°C for 10 min. After centrifugation at 1,000 g for 10 min 
at 4°C, supernatants were removed (fraction N1). Pellets (fraction N2) 
were resuspended in the SDS sample buffer (125 mM Tris-HCl, pH 6.8, 4% 
SDS, and 20% glycerol, colored with bromophenol blue) and sonicated. 
For acid extraction of histones, fraction N2 was incubated with 200 mM 
sulfuric acid at 4°C for 30 min and centrifuged at 20,000 g for 10 min at 
4°C. Supernatants were supplemented with 1/4 vol of 100% trichloroacetic 
acid and incubated at 4°C for 10 min. After centrifugation at 20,000 g for 
5 min at 4°C, pellets were rinsed with cold acetone, dried, and resus-
pended in the SDS sample buffer. For the preparation of cell lysates (Figs. 
7–9), cells were suspended in lysis buffer (50 mM Tris-HCl, pH 7.4, 150 
mM NaCl, 1% NP-40, 1 mM EDTA, 1 mM DTT, 1 mM sodium orthovana-
date, 1.25 mM sodium ﬂ  uoride, 100 nM okadaic acid, 10 mM β-glycero-
phosphate, and Complete protease inhibitors) at 4°C for 30 min. After 
centrifugation at 20,000 g at 4°C for 10 min, the supernatants were used 
for immunoblotting analyses using anti-Rb, cyclin A, p16, p21, p53, 
P-p53, Ras, and actin antibodies. Pellets were suspended in the SDS 
  sample buffer and used for immunoblotting analyses using anti-H1, 
HMGA2, and H2B antibodies.
For mass spectrometry, protein bands were cut out from SDS-PAGE 
gels and digested with trypsin (Promega). The eluted peptides were ana-
lyzed with a hybrid mass spectrometer (QSTAR XL; Applied Biosystems) 
equipped with a nanoelectrospray ion source (MDS Protana).
For immunoblotting, proteins were loaded onto SDS-PAGE gels, 
transferred onto polyvinylidene ﬂ   uoride membranes (Millipore), and de-
tected with ECL immunoblotting detection reagents (GE Healthcare).
RT-PCR and SA–𝗃-gal staining
RT-PCR was performed with an RNA PCR kit (Takara) according to the 
manufacturer’s protocol. PCR primers used in this study are HIST1H1D 
(5′-C  A  A  G  C  C  T  A  G  G  A  A  G  C  C  T  G  C  T  G-3′   and 5′-A  A  A  G  G  G  G  A  A  C  G  T  C  C  C  G-
C  C  A  G-3′  ) and GAPDH (5′-A  T  T  T  G  G  T  C  G  T  A  T  T  G  G  G  C  G  C  C  T  G  G  T  C  -3′ and 
5′-T  T  G  T  C  A  T  A  C  T  T  C  T  C  A  T  G  G  T  T  C  A  C  A  C  -3′).
For SA–β-gal staining, cells were ﬁ  xed with 0.5% glutaraldehyde in 
PBS at room temperature for 10 min and incubated in staining solution 
(0.65 mg/ml X-Gal [5-bromo-4-chloro-3-indolyl-β-D-galactoside], 5 mM 
K3Fe(CN)6, 5 mM K4Fe(CN)6, and 1 mM MgCl2 in PBS, pH 6.0) at 
37°C overnight.
Online supplemental material
Fig. S1 shows the speciﬁ  cities of FISH signals and anti-BrdU IF signals. Fig. S2 
shows the speciﬁ  city of antihistone H1 sheep antibody. Fig. S3 shows the co-
localization of N-fusion H1 and mitotic chromosomes and the enlargement of 
WI-38 cells expressing N-fusion H1. Fig. S4 shows the effect of HA-HMGA2 
expression on cell growth and SAHF formation. Fig. S5 shows the effect of 
N-fusion 1 expression on SAHF formation. Online supplemental material is 
available at http://www.jcb.org/cgi/content/full/jcb.200604005/DC1.
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